Rockwell Medical Tech (NASDAQ:RMTI)
The Company manufactures, sells and distributes hemodialysis concentrates and other ancillary medical products and supplies used in the treatment of patients with End Stage Renal Disease.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
By year end Rockwell will be in very detailed talks on a licensing deal with a major European Drug Company
Recs
I'm picking this stock for the long haul based on good insider ownership.
Recs
betting on a hot next week
Recs
The company is pursuing an area of great need (management of iron deficiency in kidney dialysis population), and is also reseraching Vitamin D administration.
Recs
This is one of my STARZ.
Here is the thought process on this STAR:
a) Divided rate over Zero
b) 3 Year Beta between -5 & +3
c) 15% + Insider ownership
d) No greater than -50% Growth rate for the last 3 years (tough last couple of years so good that insiders are still owning the stocks)
e) Current CAPS rating between 3 Stars & 5 Stars
Open to all Industries and Sectors screened this down to just 250 stocks. I like round numbers. 12 of them I already own through other screening tools. I tend to be somewhat conservative but looking for 3 things at this point in my investing:
1. Stability & Strength
2. Yield and Modest Growth
3. Strong Position within a sector regardless of whether the
entire sector is strong or not. Each sector has to perform to some degree for the whole world economy to function. I am looking for 5 or more years down the road, ROI, and Growth. Not looking for rockets, just stars. This is a Star!!
Recs
Biz-ounce from today's fall. In at $6.20, looking to exit $7
Recs
SFP will gain FDA approval and create huge market for the company's products
Recs
Will be on anyone's radar in 12 months
Recs
Here is a stock that I own and have watched for a couple years now, Rockwell Medical Technologies, I have wanted to have it on CAPS since I started but alas its not big enough...yet. I will give this to you as quickly as I can, they are in the dialyses market producing a revalutionary drug that makes the process easier, quicker and cheaper, great for the patient and the hospitals its used in. If you take a look at their ratios and growth rates you see some interesting numbers, mainly that thier sales are growing and the arent making money. Well that doesnt sound wonderful, well it might if you know the details, why they arent taking home a lot of cash is one reason, the drug is now in the second stage and should be going to the final stage by the end of this year, phase 3. Everything has been going very smooth and looks like it will stay that way, but the company is funding all this themselves, not with debt but using the cash they generate, so when this drug hits and is done with testing they will have no debt that most all companies have to deal with after. Even if this drug doesnt work and everything ends up going bust the core business that they are in is seeing great growth and the management of the company seems great to boot. Take a look, it just had a big spike on the news that monday June 29th it will be a part of the Russell 2000 index. But we should see a lot more trading going on over the next weeks.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 9 of 9